Amy E Rothberg, MD, DABOM

Amy Rothberg
Clinical Professor of Internal Medicine
Medical School
Adjunct Clinical Associate Professor of Nutritional Sciences
School of Public Health
Available to mentor
Amy E Rothberg, MD, DABOM
Amy Rothberg
Clinical Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • Manage Your Profile

  • About

    Amy E. Rothberg, MD, DABOM is Clinical Professor of Medicine in the Division of Metabolism, Endocrinology and Diabetes and Professor of Nutritional Sciences in the School of Public Health at the University of Michigan. She is the Director of the University of Michigan Weight Management Program, a 2-year intensive behavioral and lifestyle program onto which there is a multifaceted research program in which patients undergo extensive baseline and interval phenotyping to identify the factors that predict successful and cost-effective long-term weight loss. Her primary research is funded by the NIH/NIDDK. Her work encompasses three major research foci: The first is on the impact of the interventions on insulin secretion, insulin action, long-term glycemia, the development of complications and comorbidities, health-related quality-of-life, and cost. The second is on the behavioral and biological determinants of weight loss and weight loss maintenance. The third is scalability of her program through telehealth and the internet and the impact on the processes and outcomes of care.

    Qualifications

    • Residency
      University of Michigan, Internal Medicine, Ann Arbor, United States
      Residency

    Center Memberships

    • Center Member
      Caswell Diabetes Institute

    Research Overview

    - Determining factors that predict successful and cost-effective long-term weight loss
    - Assessing the neurobiopsychosocial adaptations that occur with weight loss
    - Evaluating implementation of a model of intensive behavioral therapy from sub-speciality care into primary care
    - Impact of weight loss on health related quality of life
    - Effects of intensive lifestyle intervention on reproductive, maternal and fetal outcomes

    Recent Publications

    See All Publications
    • Additional Scholarship
      JCEM study quoted in Medscape article, "Concerns Continue Over Proposed New Obesity Definitions"
      Melville N. 2026 Apr 9;
    • Journal Article
      179. Evidence of Stimuli Type Influencing Inhibitory Control Ability in Individuals With Overweight or Obesity: A Meta-Analysis of Go/No-Go Behavioral Studies
      Eichstaedt J, Rothberg A, Burghardt P, Homayouni R, Stanley J. Biological Psychiatry, 2026 Apr 28; 99 (10): s175 - s176. DOI:10.1016/j.biopsych.2026.03.413
    • Journal Article
      Defining disease or delaying care? A conceptual and clinical appraisal of the Lancet obesity framework.
      Muniyappa R, Chukir T, Desai D, Weintraub MA, Corrigan MD, Gianchandani R, Rothberg AE. J Clin Endocrinol Metab, 2026 Apr 2; DOI:10.1210/clinem/dgag097
      PMID: 41925581
    • Additional Scholarship
      JCEM study quoted in Endocrine Today article, “Endocrine Society communication outlines limitations of Lancet Commission obesity report”
      Monostra M. 2026 Apr 9;
    • Additional Scholarship
      JCEM study quoted in Medpage article, “Proposed Obesity Criteria Could Delay Care, Top Society Warns"
      Monaco K. 2026 Apr 9;
    • Presentation
      Theory to Application, Application to Insight: The interplay of Research and Practice
      Rothberg A. 2026 Apr 13;
    • Additional Scholarship
      "Four-Drug Regimen Superior to Escalating Metformin in T2D: EFFORT Trial”, Medscape
      Rothberg A. 2026 Mar 20;
    • Additional Scholarship
      "Four-Drug Regimen Superior to Escalating Metformin in T2D: EFFORT Trial”, Medscape
      Rothberg A. 2026 Mar 20;

    Featured News & Stories

    person stepping one foot on scale
    Department News

    New Findings on Obesity Identification by BMI Without Diagnosis

    Explore the latest study in the Journal of Clinical Endocrinology & Metabolism, co-authored by Dr. Amy Rothberg, on the development of a clinical measure for identifying obesity patients without a formal diagnosis.
    Amy Rothberg showing a male atient and app on her phone
    Health Lab

    Dr. Rothberg’s Michigan Answer: Reversing Type 2 diabetes

    What do you do when you know a disease is reversible, even curable, and yet each year millions of people still suffer from it? For Amy Rothberg, M.D., you find a whole new way to help people not only lose weight, but in some cases even reverse a diabetes diagnosis.